Amplicore
Latest round
- Seed
Last raised
- Mar 2021
Total raised
- $4M
Investors
- 4
About Amplicore
Amplicore, Inc. focuses on innovative therapies for musculoskeletal conditions.Amplicore specializes in the development of injectable therapeutics aimed at treating degenerative musculoskeletal disorders, specifically targeting conditions such as osteoarthritis, cartilage damage, degenerative disc disease, and acute meniscus tears. Their primary offerings, AM1101 for osteoarthritis and AM3101 for meniscal repair, are designed utilizing a regenerative approach that relieves pain while addressing the underlying causes of joint discomfort.Amplicore generates revenue through direct sales of its injectable therapeutics to healthcare providers, hospitals, and clinics specializing in orthopedics and pain management. The transaction structure follows a Business-to-Business (B2B) model, where healthcare facilities purchase Amplicore's products to integrate them into their treatment protocols. In addition to advancing these products, the company aims to explore opportunities for expansion into new geographic markets, enhancing its reach to a broader clientele by targeting regions with high demand for innovative musculoskeletal treatments.
Who invested in Amplicore
4 investors across 1 round
See all investors in Amplicore
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Mar 25, 2021
Amount
$4M
Investors
Questions about Amplicore
Who invested in Amplicore?
Amplicore has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Amplicore raised?
Amplicore has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Amplicore last raise money?
Amplicore's most recent round on record is a Seed, in Mar 2021.
What does Amplicore do?
Amplicore is a biotechnology company.
Where is Amplicore headquartered?
Amplicore is headquartered in Mason, US.
Which VCs invest in companies like Amplicore?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Amplicore's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Amplicore? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.